Home > Boards > US Listed > Medical - Drugs > Abbvie (ABBV)

No—see #msg-150309079.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 724
Posts 109,595
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
AbbVie Prices $30 Billion of Senior Unsecured Notes PR Newswire (US) - 11/12/2019 9:45:00 PM
AbbVie Sells $30 Billion of Bonds -- 2nd Update Dow Jones News - 11/12/2019 6:39:00 PM
AbbVie Prepares Large Bond Sale -- Update Dow Jones News - 11/12/2019 3:34:00 PM
AbbVie Prepares Large Bond Sale to Fund Allergan Purchase Dow Jones News - 11/12/2019 1:32:00 PM
New Positive Data for RINVOQ™ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 201... PR Newswire (US) - 11/12/2019 11:15:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 11/12/2019 10:19:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/11/2019 9:56:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/8/2019 5:15:21 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/8/2019 12:15:16 PM
Form 8.3 - Allergan Plc Dow Jones News - 11/8/2019 10:01:00 AM
J&J's Janssen Gets Health Canada OK for Expanded Imbruvica Use Dow Jones News - 11/8/2019 9:17:00 AM
J&J's Janssen Seeks FDA OK for Expanded Imbruvica Use Dow Jones News - 11/8/2019 8:27:00 AM
AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for th... PR Newswire (US) - 11/8/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 6:07:52 AM
AbbVie Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Allergan Notes PR Newswire (US) - 11/7/2019 8:41:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 9:18:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 3:31:31 PM
AbbVie Announces Launch of Private Offering of Senior Unsecured Notes PR Newswire (US) - 11/6/2019 3:06:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 10:18:15 AM
Form 8.3 - [AbbVie. Inc] Dow Jones News - 11/6/2019 9:58:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/6/2019 9:45:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/5/2019 10:10:00 AM
Form 8.3 - [Alletgan Plc] Dow Jones News - 11/4/2019 10:09:00 AM
AbbVie to Showcase Depth of Immunology Portfolio and Pipeline at the 2019 ACR/ARP Annual Meeting PR Newswire (US) - 11/4/2019 8:31:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 11/1/2019 11:40:00 AM
DewDiligence Member Level  Friday, 09/20/19 06:13:18 PM
Re: Bickema post# 492
Post # of 509 
No—see #msg-150309079.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist